Competitions for smoking cessation.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
20 02 2019
Historique:
pubmed: 21 2 2019
medline: 13 4 2019
entrez: 21 2 2019
Statut: epublish

Résumé

Competitions might encourage people to undertake and/or reinforce behaviour change, including smoking cessation. Competitions involve individuals or groups having the opportunity to win a prize following successful cessation, either through direct competition or by entry into a lottery or raffle. To determine whether competitions lead to higher long-term smoking quit rates. We also aimed to examine the impact on the population, the costs, and the unintended consequences of smoking cessation competitions. This review has merged two previous Cochrane reviews. Here we include studies testing competitions from the reviews 'Competitions and incentives for smoking cessation' and 'Quit & Win interventions for smoking cessation'. We updated the evidence by searching the Cochrane Tobacco Addiction Group Specialized Register in June 2018. We considered randomized controlled trials (RCTs), allocating individuals, workplaces, groups within workplaces, or communities to experimental or control conditions. We also considered controlled studies with baseline and post-intervention measures in which participants were assigned to interventions by the investigators. Participants were smokers, of any age and gender, in any setting. Eligible interventions were contests, competitions, lotteries, and raffles, to reward cessation and continuous abstinence in smoking cessation programmes. For this update, data from new studies were extracted independently by two review authors. The primary outcome measure was abstinence from smoking at least six months from the start of the intervention. We performed meta-analyses to pool study effects where suitable data were available and where the effect of the competition component could be separated from that of other intervention components, and report other findings narratively. Twenty studies met our inclusion criteria. Five investigated performance-based reward, where groups of smokers competed against each other to win a prize (N = 915). The remaining 15 used performance-based eligibility, where cessation resulted in entry into a prize draw (N = 10,580). Five of these used Quit & Win contests (N = 4282), of which three were population-level interventions. Fourteen studies were RCTs, and the remainder quasi-randomized or controlled trials. Six had suitable abstinence data for a meta-analysis, which did not show evidence of effectiveness of performance-based eligibility interventions (risk ratio (RR) 1.16, 95% confidence interval (CI) 0.77 to 1.74, N = 3201, I At present, it is impossible to draw any firm conclusions about the effectiveness, or a lack of it, of smoking cessation competitions. This is due to a lack of well-designed comparative studies. Smoking cessation competitions have not been shown to enhance long-term cessation rates. The limited evidence suggesting that population-based Quit & Win contests at local and regional level might deliver quit rates above baseline community rates has not been tested adequately using rigorous study designs. It is also unclear whether the value or frequency of possible cash reward schedules influence the success of competitions. Future studies should be designed to compensate for the substantial biases in the current evidence base.

Sections du résumé

BACKGROUND
Competitions might encourage people to undertake and/or reinforce behaviour change, including smoking cessation. Competitions involve individuals or groups having the opportunity to win a prize following successful cessation, either through direct competition or by entry into a lottery or raffle.
OBJECTIVES
To determine whether competitions lead to higher long-term smoking quit rates. We also aimed to examine the impact on the population, the costs, and the unintended consequences of smoking cessation competitions.
SEARCH METHODS
This review has merged two previous Cochrane reviews. Here we include studies testing competitions from the reviews 'Competitions and incentives for smoking cessation' and 'Quit & Win interventions for smoking cessation'. We updated the evidence by searching the Cochrane Tobacco Addiction Group Specialized Register in June 2018.
SELECTION CRITERIA
We considered randomized controlled trials (RCTs), allocating individuals, workplaces, groups within workplaces, or communities to experimental or control conditions. We also considered controlled studies with baseline and post-intervention measures in which participants were assigned to interventions by the investigators. Participants were smokers, of any age and gender, in any setting. Eligible interventions were contests, competitions, lotteries, and raffles, to reward cessation and continuous abstinence in smoking cessation programmes.
DATA COLLECTION AND ANALYSIS
For this update, data from new studies were extracted independently by two review authors. The primary outcome measure was abstinence from smoking at least six months from the start of the intervention. We performed meta-analyses to pool study effects where suitable data were available and where the effect of the competition component could be separated from that of other intervention components, and report other findings narratively.
MAIN RESULTS
Twenty studies met our inclusion criteria. Five investigated performance-based reward, where groups of smokers competed against each other to win a prize (N = 915). The remaining 15 used performance-based eligibility, where cessation resulted in entry into a prize draw (N = 10,580). Five of these used Quit & Win contests (N = 4282), of which three were population-level interventions. Fourteen studies were RCTs, and the remainder quasi-randomized or controlled trials. Six had suitable abstinence data for a meta-analysis, which did not show evidence of effectiveness of performance-based eligibility interventions (risk ratio (RR) 1.16, 95% confidence interval (CI) 0.77 to 1.74, N = 3201, I
AUTHORS' CONCLUSIONS
At present, it is impossible to draw any firm conclusions about the effectiveness, or a lack of it, of smoking cessation competitions. This is due to a lack of well-designed comparative studies. Smoking cessation competitions have not been shown to enhance long-term cessation rates. The limited evidence suggesting that population-based Quit & Win contests at local and regional level might deliver quit rates above baseline community rates has not been tested adequately using rigorous study designs. It is also unclear whether the value or frequency of possible cash reward schedules influence the success of competitions. Future studies should be designed to compensate for the substantial biases in the current evidence base.

Identifiants

pubmed: 30784046
doi: 10.1002/14651858.CD013272
pmc: PMC6953205
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD013272

Subventions

Organisme : Department of Health
ID : SRP/16/114/20
Pays : United Kingdom

Références

Cochrane Database Syst Rev. 2017 Nov 17;11:CD003289
pubmed: 29148565
Cancer Pract. 1995 May-Jun;3(3):157-63
pubmed: 7599672
Contemp Clin Trials. 2015 Nov;45(Pt B):449-457
pubmed: 26362691
Hygie. 1993;12(1):14-8
pubmed: 8462982
J Consult Clin Psychol. 1985 Dec;53(6):905-12
pubmed: 4086690
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004986
pubmed: 18843674
Nicotine Tob Res. 2003 Apr;5(2):205-13
pubmed: 12745493
Health Psychol. 2013 Sep;32(9):950-7
pubmed: 24001245
Am J Health Promot. 1999 Jul-Aug;13(6):347-57
pubmed: 10557507
Am J Public Health. 1997 Jul;87(7):1201-4
pubmed: 9240113
Addiction. 2016 Feb;111(2):331-9
pubmed: 26767340
Am J Health Promot. 1998 Nov-Dec;13(2):105-11
pubmed: 10346656
Health Psychol Rev. 2014;8(3):286-95
pubmed: 25053215
Curr Addict Rep. 2016 Mar;3(1):9-18
pubmed: 27158581
Am J Public Health. 1987 Feb;77(2):211-3
pubmed: 3541653
Am J Health Promot. 2005 Nov-Dec;20(2):117-26
pubmed: 16295703
Prev Med. 2004 May;38(5):662-7
pubmed: 15066370
Contemp Clin Trials. 2013 May;35(1):97-105
pubmed: 23466754
Nicotine Tob Res. 2016 Dec;18(12):2177-2184
pubmed: 27245237
Cochrane Database Syst Rev. 2017 Sep 12;9:CD004305
pubmed: 28898403
Nicotine Tob Res. 2016 Oct;18(10):2036-40
pubmed: 27154970
JAMA Intern Med. 2017 Dec 1;177(12):1790-1797
pubmed: 29059277
Nicotine Tob Res. 2012 Mar;14(3):351-60
pubmed: 22157229
Behav Res Ther. 1980;18(1):45-50
pubmed: 7369987
Prev Med. 1999 Dec;29(6 Pt 1):590-8
pubmed: 10600442
Nihon Koshu Eisei Zasshi. 2004 May;51(5):357-70
pubmed: 15216971
Psychopharmacology (Berl). 1995 May;119(2):193-204
pubmed: 7659767
Cochrane Database Syst Rev. 2013 Oct 23;(10):CD001055
pubmed: 24154953
Am J Public Health. 1986 Jul;76(7):819-20
pubmed: 3717471
Cochrane Database Syst Rev. 2015 May 18;(5):CD004307
pubmed: 25983287
Am J Public Health. 1987 Oct;77(10):1340-1
pubmed: 3631371
Nicotine Tob Res. 2007 Oct;9(10):1043-51
pubmed: 17943620
Drug Alcohol Depend. 2014 Jul 1;140:208-12
pubmed: 24793364
Addict Behav. 1989;14(2):187-95
pubmed: 2658483
Trials. 2012 Jul 20;13:113
pubmed: 22818493
J Occup Environ Med. 2012 May;54(5):610-4
pubmed: 22476113
J Subst Abuse Treat. 2005 Jun;28(4):305-12
pubmed: 15925264
Drug Alcohol Depend. 2007 Oct 8;90(2-3):224-7
pubmed: 17475418
Eur J Health Econ. 2018 Dec;19(9):1319-1333
pubmed: 29687268
Health Policy. 1993 Nov;26(1):43-53
pubmed: 10130845
Nicotine Tob Res. 2009 Jun;11(6):739-49
pubmed: 19443788
Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):12-8
pubmed: 16434580
Tob Control. 2000;9 Suppl 2:II56-9
pubmed: 10841592
Am J Health Promot. 1991 Jan-Feb;5(3):192-9
pubmed: 10148668
Tob Control. 2000;9 Suppl 3:III67-9
pubmed: 10982912
Chronic Dis Can. 2006;27(2):77-84
pubmed: 16867242
Tob Control. 2000 Sep;9(3):303-9
pubmed: 10982574
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004986
pubmed: 15846739
Addiction. 2002 Oct;97(10):1317-28; discussion 1325
pubmed: 12359036
Prev Med. 2000 Dec;31(6):742-51
pubmed: 11133342
N Engl J Med. 2009 Jul 23;361(4):331-3
pubmed: 19625714
Exp Clin Psychopharmacol. 2007 Apr;15(2):176-86
pubmed: 17469941
Prev Med. 2004 Sep;39(3):543-50
pubmed: 15313094
Behav Modif. 2000 Apr;24(2):184-201
pubmed: 10804679
Behav Res Ther. 1981;19(2):117-23
pubmed: 7271687
Addiction. 2008 Jun;103(6):1009-18
pubmed: 18482424
Contemp Clin Trials. 2012 Jan;33(1):197-205
pubmed: 22005174
Nicotine Tob Res. 2006 Jun;8(3):473-80
pubmed: 16801305
J Behav Med. 1988 Aug;11(4):407-21
pubmed: 3070047
Addict Behav. 1993 Jul-Aug;18(4):455-64
pubmed: 8213300
J Public Health Manag Pract. 2006 Jan-Feb;12(1):52-9
pubmed: 16340516
J Occup Environ Med. 2011 Jan;53(1):62-7
pubmed: 21187795
J Clin Psychiatry. 2014 Apr;75(4):336-43
pubmed: 24345356
BMJ. 2015 Jan 27;350:h134
pubmed: 25627664
JAMA. 2014 Mar 5;311(9):909-10
pubmed: 24493405
Drug Alcohol Depend. 2014 Jan 1;134:391-395
pubmed: 24128381
Nicotine Tob Res. 2014 Nov;16(11):1436-45
pubmed: 24935755
Am J Public Health. 1986 Feb;76(2):198-200
pubmed: 3946702
N Engl J Med. 2009 Feb 12;360(7):699-709
pubmed: 19213683
Addiction. 2012 Oct;107(10):1868-77
pubmed: 22716774
Prev Med. 2012 Nov;55 Suppl:S2-6
pubmed: 22554884
Prog Clin Biol Res. 1989;293:231-42
pubmed: 2498905
Prev Med. 1987 Mar;16(2):221-34
pubmed: 3588563
Am J Health Promot. 1994 Nov-Dec;9(2):85-7, 124
pubmed: 10150715
Health Econ. 2001 Jul;10(5):399-410
pubmed: 11466802
Am J Public Health. 1987 Feb;77(2):162-5
pubmed: 3099586
Cochrane Database Syst Rev. 2011 Apr 13;(8):ED000027
pubmed: 21833985
Scand J Soc Med. 1995 Sep;23(3):193-201
pubmed: 8602490
Health Educ Res. 2000 Aug;15(4):469-83
pubmed: 11066464
Tob Control. 1999 Summer;8(2):175-81
pubmed: 10478402
Addict Behav. 1997 Jan-Feb;22(1):131-7
pubmed: 9022879
Prev Med. 1992 Jan;21(1):74-87
pubmed: 1738770
Addict Behav. 1990;15(5):403-11
pubmed: 2248113
BMJ. 2009 Apr 09;338:b1415
pubmed: 19359291
Exp Clin Psychopharmacol. 2007 Feb;15(1):58-66
pubmed: 17295585
Prev Med. 2012 Nov;55 Suppl:S24-32
pubmed: 22525802
Can J Public Health. 1994 Mar-Apr;85(2):95-8
pubmed: 8012926
Am J Public Health. 1993 Sep;83(9):1231-8
pubmed: 8362997
Drug Alcohol Depend. 2014 Jul 1;140:63-8
pubmed: 24768410
J Psychoactive Drugs. 2007 Dec;39(4):487-97
pubmed: 18303706
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004307
pubmed: 18646105
Prev Med. 2001 Oct;33(4):229-38
pubmed: 11570825
Behav Res Ther. 1983;21(4):425-33
pubmed: 6626113
Am J Public Health. 2002 Feb;92(2):274-9
pubmed: 11818305
Am J Health Promot. 1991 Jul-Aug;5(6):420-5
pubmed: 10146840
Prev Med. 2012 Nov;55 Suppl:S33-40
pubmed: 22227223
Drug Alcohol Depend. 2009 Oct 1;104 Suppl 1:S100-5
pubmed: 19442460
Birth. 1984 Winter;11(4):217-24
pubmed: 6568824
Drug Alcohol Depend. 2013 Dec 15;133(3):845-51
pubmed: 24075226
N Engl J Med. 2015 May 28;372(22):2108-17
pubmed: 25970009
Prev Med. 2015 Jul;76:20-5
pubmed: 25773472
Scand J Public Health. 2005;33(5):343-52
pubmed: 16265801
J Subst Abuse Treat. 2017 Jan;72:103-110
pubmed: 27449226
Am J Prev Med. 2013 Nov;45(5):533-42
pubmed: 24139765
Addiction. 2010 Nov;105(11):2023-30
pubmed: 20840188
Nicotine Tob Res. 2004 Dec;6(6):1015-20
pubmed: 15801574
Addict Behav. 1991;16(5):183-93
pubmed: 1776536
Prev Med. 1986 Jan;15(1):28-34
pubmed: 3714657
J Health Commun. 2000 Oct-Dec;5(4):293-303
pubmed: 11191015
PLoS One. 2014 Mar 11;9(3):e90347
pubmed: 24618584
Int J Behav Med. 2013 Mar;20(1):114-20
pubmed: 22094998
Am J Health Promot. 1990 Jul;4(6):429-34
pubmed: 22204621
Addict Behav. 1989;14(2):121-8
pubmed: 2728951
Exp Clin Psychopharmacol. 2010 Jun;18(3):221-8
pubmed: 20545386
Am J Public Health. 1990 May;80(5):601-3
pubmed: 2109545
Nicotine Tob Res. 2002 May;4(2):149-59
pubmed: 12028847
Nicotine Tob Res. 2004 Apr;6 Suppl 2:S163-79
pubmed: 15203819
J Public Health Manag Pract. 2006 Jan-Feb;12(1):44-51
pubmed: 16340515
Can J Public Health. 1998 Jan-Feb;89(1):37-42
pubmed: 9524389
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004307
pubmed: 15846705
J Behav Med. 1990 Aug;13(4):403-18
pubmed: 2246786
Drug Alcohol Depend. 2007 Sep;90 Suppl 1:S85-91
pubmed: 17101239
Prev Med. 1989 Nov;18(6):867-76
pubmed: 2626419
Am J Epidemiol. 1985 Jul;122(1):135-48
pubmed: 4014191
Am J Health Promot. 1991 Jan-Feb;5(3):200-7
pubmed: 10148669
JAMA. 1984 Feb 17;251(7):911-5
pubmed: 6363731
Nicotine Tob Res. 2010 May;12(5):483-8
pubmed: 20339141
WMJ. 2005 May;104(4):45-9
pubmed: 16117234
Am J Health Promot. 1994 May-Jun;8(5):328-30
pubmed: 10172074
Health Educ Res. 1997 Mar;12(1):129-38
pubmed: 10166900
Prev Med. 2014 Nov;68:51-7
pubmed: 24704135
Chronic Dis Can. 2000;21(2):54-61
pubmed: 11007655
Cogn Behav Pract. 2013 Nov;20(4):501-516
pubmed: 33239855
Prev Med. 2000 Oct;31(4):299-307
pubmed: 11006054
Addict Behav. 2009 Aug;34(8):705-8
pubmed: 19411145
Nicotine Tob Res. 2003 Feb;5(1):13-25
pubmed: 12745503
Cochrane Database Syst Rev. 2011 Apr 13;(4):CD004307
pubmed: 21491388
Prev Med. 1993 May;22(3):423-32
pubmed: 8327422
Drug Alcohol Depend. 2006 Nov 8;85(2):138-41
pubmed: 16720082
BMC Public Health. 2014 Jul 28;14:761
pubmed: 25074396
Eur J Cancer Prev. 1992 Aug;1(5):361-6
pubmed: 1463988
Am J Prev Med. 2010 Feb;38(2 Suppl):S263-74
pubmed: 20117611
Am J Health Promot. 2012 Mar-Apr;26(4):204-7
pubmed: 22375568
Am J Health Promot. 1998 May-Jun;12(5):307-20
pubmed: 10181140
Am J Public Health. 1995 Feb;85(2):263-4
pubmed: 7856789
Nicotine Tob Res. 2017 Mar 01;19(3):290-298
pubmed: 27613901
J Natl Med Assoc. 1995 Apr;87(4):291-300
pubmed: 7752283
Prev Med. 1997 May-Jun;26(3):373-81
pubmed: 9144762
Am J Public Health. 1994 Jul;84(7):1086-93
pubmed: 8017530

Auteurs

Thomas R Fanshawe (TR)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH